BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, Ohgi K, Nakanuma Y, Uesaka K. The Evaluation of the Eighth Edition of the AJCC/UICC Staging System for Intrahepatic Cholangiocarcinoma: a Proposal of a Modified New Staging System. J Gastrointest Surg 2020;24:786-95. [PMID: 31012045 DOI: 10.1007/s11605-019-04185-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Chang Y, Li Q, Wu Q, Chi L, Bi X, Zeng Q, Huo H. Impact of surgical strategies on the survival of gallbladder cancer patients: analysis of 715 cases. World J Surg Oncol 2020;18:142. [PMID: 32590998 DOI: 10.1186/s12957-020-01915-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Turner KM, Delman AM, Kharofa J, Olowokure O, Sohal D, Quillin RC, Shah SA, Ahmad SA, Patel SH, Wilson GC. A National Assessment of T2 Staging for Intrahepatic Cholangiocarcinoma and the Poor Prognosis Associated with Multifocality. Ann Surg Oncol 2022. [PMID: 35441906 DOI: 10.1245/s10434-022-11762-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Liu H, Qiu G, Hu F, Wu H. Fibrinogen/albumin ratio index is an independent predictor of recurrence-free survival in patients with intrahepatic cholangiocarcinoma following surgical resection. World J Surg Oncol 2021;19:218. [PMID: 34284775 DOI: 10.1186/s12957-021-02330-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Kim YY, Yeom SK, Shin H, Choi SH, Rhee H, Park JH, Cho ES, Park S, Lee SS, Park MS. Clinical Staging of Mass-Forming Intrahepatic Cholangiocarcinoma: Computed Tomography Versus Magnetic Resonance Imaging. Hepatol Commun 2021;5:2009-18. [PMID: 34559470 DOI: 10.1002/hep4.1774] [Reference Citation Analysis]
5 RuiYang W, ZhiMing Y, Jiao F, Liang Z, Gang Z. Evaluation and Recommendation of the 8th Edition of American Joint Committee on Cancer (AJCC) Staging System for Intrahepatic Cholangiocarcinoma (ICC) in 820 Patients from the Surveillance, Epidemiology, and End Results (SEER) Database. J Gastrointest Surg 2021;25:145-54. [PMID: 32193847 DOI: 10.1007/s11605-020-04557-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zhang XF, Xue F, He J, Alexandrescu S, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Soubrane O, Martel G, Koerkamp BG, Itaru E, Lv Y, Pawlik TM. Proposed modification of the eighth edition of the AJCC staging system for intrahepatic cholangiocarcinoma. HPB (Oxford) 2021:S1365-182X(21)00060-5. [PMID: 33814298 DOI: 10.1016/j.hpb.2021.02.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Li Q, Che F, Wei Y, Jiang HY, Zhang Y, Song B. Role of noninvasive imaging in the evaluation of intrahepatic cholangiocarcinoma: from diagnosis and prognosis to treatment response. Expert Rev Gastroenterol Hepatol 2021;15:1267-79. [PMID: 34452581 DOI: 10.1080/17474124.2021.1974294] [Reference Citation Analysis]
8 Chen Y, Weng S. Reappraisal of the T Category for Solitary Intrahepatic Cholangiocarcinoma by Tumor Size in 611 Early-Stage (T1-2N0M0) Patients After Hepatectomy: a Surveillance, Epidemiology, and End Results (SEER) Analysis. J Gastrointest Surg 2021;25:1989-99. [PMID: 33140321 DOI: 10.1007/s11605-020-04833-x] [Reference Citation Analysis]